These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36894916)

  • 1. ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies.
    Perréard M; Florent R; Divoux J; Grellard JM; Lequesne J; Briand M; Clarisse B; Rousseau N; Lebreton E; Dubois B; Harter V; Lasne-Cardon A; Drouet J; Johnson A; Le Page AL; Bazille C; Jeanne C; Figeac M; Goardon N; Vaur D; Micault E; Humbert M; Thariat J; Babin E; Poulain L; Weiswald LB; Bastit V
    BMC Cancer; 2023 Mar; 23(1):223. PubMed ID: 36894916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer.
    Divoux J; Florent R; Jacobs M; Lequesne J; Grellard JM; San C; Grossi S; Kerdja K; Clarisse B; Boudier G; Cherifi F; Briand M; Dolivet E; Johnson A; Dubois B; Harter V; Lacroix J; Raboutet C; Marie B; Rousseau N; Blanc-Fournier C; Vaur D; Figeac M; Poulain L; Weiswald LB; Emile G
    BMC Cancer; 2023 Sep; 23(1):883. PubMed ID: 37726786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers.
    Thorel L; Divoux J; Lequesne J; Babin G; Morice PM; Florent R; Desmartin G; Lecouflet L; Marde Alagama C; Leconte A; Clarisse B; Briand M; Rouzier R; Gaichies L; Martin-Françoise S; Le Brun JF; Denoyelle C; Vigneron N; Jeanne C; Blanc-Fournier C; Leman R; Vaur D; Figeac M; Meryet-Figuiere M; Joly F; Weiswald LB; Poulain L; Dolivet E
    BMC Cancer; 2024 Jun; 24(1):701. PubMed ID: 38849726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the treatment sensitivity of patient-derived organoids with treatment outcomes in patients with head and neck cancer (SOTO): protocol for a prospective observational study.
    Vasiliadou I; Cattaneo C; Chan PYK; Henley-Smith R; Gregson-Williams H; Collins L; Wojewodka G; Guerrero-Urbano T; Jeannon JP; Connor S; Davis J; Pasto A; Mustapha R; Ng T; Kong A
    BMJ Open; 2024 Oct; 14(10):e084176. PubMed ID: 39389599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
    Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
    Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma.
    Thorel L; Morice PM; Paysant H; Florent R; Babin G; Thomine C; Perréard M; Abeilard E; Giffard F; Brotin E; Denoyelle C; Villenet C; Sebda S; Briand M; Joly F; Dolivet E; Goux D; Blanc-Fournier C; Jeanne C; Villedieu M; Meryet-Figuiere M; Figeac M; Poulain L; Weiswald LB
    J Exp Clin Cancer Res; 2023 Oct; 42(1):260. PubMed ID: 37803448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy.
    Driehuis E; Kolders S; Spelier S; Lõhmussaar K; Willems SM; Devriese LA; de Bree R; de Ruiter EJ; Korving J; Begthel H; van Es JH; Geurts V; He GW; van Jaarsveld RH; Oka R; Muraro MJ; Vivié J; Zandvliet MMJM; Hendrickx APA; Iakobachvili N; Sridevi P; Kranenburg O; van Boxtel R; Kops GJPL; Tuveson DA; Peters PJ; van Oudenaarden A; Clevers H
    Cancer Discov; 2019 Jul; 9(7):852-871. PubMed ID: 31053628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological Factors as Predictors for Establishment of Patient Derived Head and Neck Squamous Cell Carcinoma Organoids.
    de Kort WWB; Millen R; Driehuis E; Devriese LA; van Es RJJ; Willems SM
    Head Neck Pathol; 2024 Jun; 18(1):59. PubMed ID: 38940869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The organoid as reliable cancer modeling in personalized medicine, does applicable in precision medicine of head and neck squamous cell carcinoma?
    Farshbaf A; Lotfi M; Zare R; Mohtasham N
    Pharmacogenomics J; 2023 May; 23(2-3):37-44. PubMed ID: 36347937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification.
    Millen R; De Kort WWB; Koomen M; van Son GJF; Gobits R; Penning de Vries B; Begthel H; Zandvliet M; Doornaert P; Raaijmakers CPJ; Geurts MH; Elias SG; van Es RJJ; de Bree R; Devriese LA; Willems SM; Kranenburg O; Driehuis E; Clevers H
    Med; 2023 May; 4(5):290-310.e12. PubMed ID: 37178682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preclinical models to establish innovative therapy strategies : Ex‑vivo assessment of head and neck tumor chemo- and immune responses].
    Wichmann G; Dietz A
    HNO; 2016 Jul; 64(7):460-9. PubMed ID: 27259639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of hydrogel-free tumoroids in head and neck squamous cell carcinoma.
    Wong M; Vasani S; Breik O; Zhang X; Kenny L; Punyadeera C
    Cancer Med; 2024 Aug; 13(16):e70129. PubMed ID: 39169896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research Progress in Head and Neck Squamous Cell Carcinoma: Best Abstracts of ICHNO 2015.
    Economopoulou P; Bourhis J; Psyrri A
    Am Soc Clin Oncol Educ Book; 2015; ():e323-8. PubMed ID: 25993192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro humanized 3D microfluidic chip for testing personalized immunotherapeutics for head and neck cancer patients.
    Al-Samadi A; Poor B; Tuomainen K; Liu V; Hyytiäinen A; Suleymanova I; Mesimaki K; Wilkman T; Mäkitie A; Saavalainen P; Salo T
    Exp Cell Res; 2019 Oct; 383(2):111508. PubMed ID: 31356815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in patient-derived tumor organoids for reconstructing TME of head and neck cancer.
    Chen L; Chen Y; Ge L; Zhang Q; Meng J
    J Oral Pathol Med; 2024 Apr; 53(4):238-245. PubMed ID: 38561906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma.
    Li Q; Chen W; Li Q; Mao J; Chen X
    Front Immunol; 2022; 13():1019967. PubMed ID: 36225931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-derived three-dimensional culture techniques model tumor heterogeneity in head and neck cancer.
    Parikh AS; Yu VX; Flashner S; Okolo OB; Lu C; Henick BS; Momen-Heravi F; Puram SV; Teknos T; Pan Q; Nakagawa H
    Oral Oncol; 2023 Mar; 138():106330. PubMed ID: 36773387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Schüttrumpf L; Marschner S; Scheu K; Hess J; Rietzler S; Walch A; Baumeister P; Kirchner T; Ganswindt U; Zitzelsberger H; Belka C; Maihoefer C
    Radiat Oncol; 2020 Jan; 15(1):7. PubMed ID: 31906998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma.
    Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C
    J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.